Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. März 2017 08:50 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Present New Data for IT-102 and IT-103 at the 7th International Conference on Fixed Combination in Cannes, France

CITY OF INDUSTRY, CA--(Marketwired - Mar 2, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
01. März 2017 15:15 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Participate in the 29th Annual ROTH Conference

CITY OF INDUSTRY, CA--(Marketwired - Mar 1, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
21. Februar 2017 09:05 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Appoints Dr. Seymour Fein as Chief Medical Officer

CITY OF INDUSTRY, CA--(Marketwired - Feb 21, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
14. Februar 2017 09:20 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Announces Key Additions to its Executive Management Team

CITY OF INDUSTRY, CA--(Marketwired - Feb 14, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
10. Februar 2017 09:27 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Completes Share Issuance at a Valuation of $0.29 Per Share

CITY OF INDUSTRY, CA--(Marketwired - Feb 10, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
07. Februar 2017 10:14 ET | Quelle: Marina Biotech

Marina Biotech Announces a License Agreement to SMARTICLES

CITY OF INDUSTRY, CA--(Marketwired - Feb 7, 2017) - Marina Biotech, Inc. (OTCQB: MRNA) a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
03. Januar 2017 08:50 ET | Quelle: Marina Biotech, Inc.

Marina Biotech Granted European Claims Covering Bacteria Mediated Gene Silencing

CITY OF INDUSTRY, CA--(Marketwired - Jan 3, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
27. Dezember 2016 08:40 ET | Quelle: Marina Biotech

Marina Biotech to Update Its tkRNAi Clinical Program at Biotech Showcase

CITY OF INDUSTRY, CA--(Marketwired - Dec 27, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
14. Dezember 2016 08:40 ET | Quelle: Marina Biotech

Philippe P. Calais to Join Marina Biotech's Board of Directors

CITY OF INDUSTRY, CA--(Marketwired - Dec 14, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
25. November 2016 07:00 ET | Quelle: Marina Biotech, Inc.

Marina Biotech to Present at the 9th Annual LD Micro Main Event

BOTHELL, WA--(Marketwired - Nov 25, 2016) - Marina Biotech, Inc. (OTCQB: MRNA) today announced that its CEO, Joseph W. Ramelli, will be presenting at the LD Micro Main Event on Thursday, December...

Vorherige Seite

Nächste Seite